BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Manufacturing

CellProthera and SKGH Forge Alliance to Advance CD34+ Cell Therapy for Ischemic Diseases in Japan

CellProthera, a regenerative cell therapy developer specializing in ischemic diseases, announced a new memorandum of understanding with Shonan Kamakur...

December 13, 2024 | News

Hong Kong’s Viva Biotech Expands Global Footprint with Strategic Boston Branch Launch

Viva Biotech Holdings Group ("Viva Biotech") announced the official establishment of its new branch in Boston, USA. As a global leader in drug re...

December 12, 2024 | News

SK pharmteco Unifies Global Brands to Establish CDMO Powerhouse

SK pharmteco, a global contract development, manufacturing, and analytical testing organization serving the pharmaceutical and cell & gene therapy indu...

December 12, 2024 | News

Thermo Fisher Enhances Cell Therapy Manufacturing with CTS Detachable Dynabeads™ for CD4+ and CD8+ T Cell Isolation

T cell isolation and controlled release delivers flexibility and control in process development, clinical trials and commercial manufacturing Thermo Fishe...

December 05, 2024 | News

GBI Biomanufacturing Expands Services with Automated Sterile Fill-Finish Capabilities

GBI Biomanufacturing (GBI), one of the world's longest serving contract development and manufacturing organizations (CDMO), is pleased to announce the expa...

November 21, 2024 | News

Samsung Biologics Secures USD 668 Million in Manufacturing Deals with Europe, Surpasses USD 4 Billion in 2024 Global Contract Value

The company will provide manufacturing services through 2031 in deals worth over USD 668 million Samsung Biologics' cumulative contract value for 2...

November 20, 2024 | News

SEKISUI Diagnostics Completes £15.7 Million cGMP Expansion for Enhanced Microbial Drug Substance Manufacturing in the UK

SEKISUI Diagnostics' microbial CDMO business announces it has completed construction of its £15.7 million ($20.7 million) cGMP capacity expansion&nbs...

November 15, 2024 | News

Thermo Fisher’s $22M OSD Investment: Shervin Hebbi on Accelerating Drug Development with Cutting-Edge Technology

In an exclusive Q&A with BioPharma APAC, Shervin Hebbi, Vice President of Oral Solid Dose (OSD) – North America at Thermo Fisher ...

November 01, 2024 | Interview

Teijin and Hilleman Laboratories Forge Strategic CDMO Partnership to Advance Cell and Gene Therapy in Asia-Pacific

Teijin Limited and Hilleman Laboratories, a biotechnology company based in Singapore, announced the signing of a Memorandum of Understanding...

October 31, 2024 | News

Merck Invests €70 Million to Triple ADC Manufacturing Capacity at St. Louis Facility, Bolstering Bioconjugation Excellence

Merck, a leading science and technology company, announced a € 70 million expansion of its ADC manufacturing capabilities and capacity at its Bioconju...

October 30, 2024 | News

WuXi Biologics Introduces High-Yield WuXia™ RidGS Platform, Setting New Standards in Non-Antibiotic Cell Line Development

WuXi Biologics , a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced the launch of WuXia™ RidGS, a hig...

October 29, 2024 | News

Asahi Kasei Medical Launches Planova™ FG1: A Next-Generation Virus Removal Filter for Enhanced Biopharmaceutical Manufacturing

Asahi Kasei Medical, a global leader in virus removal solutions, proudly announces the launch of the Planova™ FG1, a next-generation virus removal fi...

October 23, 2024 | News

Samsung Biologics Inks $1.24 Billion Manufacturing Agreement with Leading Asia Pharma

Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), announced a contract manufacturing deal with an As...

October 23, 2024 | News

Samsung Biologics Introduces S-HiCon™ Platform to Optimize High-Concentration Drug Formulations

S-HiConTM is designed to maximize drug delivery and stability through high-concentration formulation The platform can address challenges associated...

October 15, 2024 | News

Stay Connected